Articles

Results 1 to 5 of 8


Pharmaceutical Company Pays $900 Million to Settle False Claims Act Allegations

USA - October 7 2022 A major pharmaceutical company agreed to settle a qui tam action for improperly influencing doctors to prescribe medications that caused the…

Rare "Qui Tam" Jury Verdict Underscores False Claims Act's Impact on Regulatory Enforcement

USA - August 5 2022 On August 3, 2022, a jury returned a rare verdict in a qui tam False Claims Act ("FCA") matter, finding a pharmaceutical company liable for $61…

SEC Awards Whistleblower Approximately $20 Million

USA - November 29 2022 The SEC awarded approximately $20 million to a whistleblower who voluntarily provided significant information and continued helpful assistance that…

Supreme Court Agrees to Consider FCA Health Insurance Fraud Case

USA - January 17 2023 The U.S. Supreme Court agreed to consider a pair of whistleblower-initiated False Claims Act cases accusing two pharmacy operators of billing…

FRB Encourages Whistleblowers to Report Misconduct

USA - September 13 2022 The Federal Reserve Board ("FRB") encouraged whistleblowers to report any misconduct by FRB-supervised banking organizations. In a policy statement…